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NaTure MicrObiOlOgy diseases [22] [23] [24] . Here, we infect intestinal and lung organoids derived from healthy human donors with Cryptosporidium. We find that Cryptosporidium can replicate within the organoids and complete its entire life cycle. Our study shows that human organoids represent physiologically relevant in vitro model systems for Cryptosporidium infection. More than 40 type I meronts, 10 type II meronts and 3 microgamonts were observed independently. e, Transmission electron microscopy of distinct stages of C. parvum life cycle after injection. Invading sporozoite and type II meront were observed in differentiated organoids at 1 day. Trophozoite was observed in expanding organoid at 1 day. PV, parasitophorous vacuole; FO, feeder organelle; AP, amylopectin granule; WB, wall-forming body; LB, lipid body; DG, dense granule; N, nucleus; RB, residual body; DB, dense band; EDC, electron dense collar; AI, anterior invagination. Scale bars, 2 μ m. Macrogamont, zygote and developing oocyst were detected in expanding organoids at 5 days. More than 2 sporozoites, 4 trophozoites, 5 type II meronts, 5 macrogamonts, 1 zygote and 3 oocysts were observed independently.
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Results
Human intestinal organoids support asexual and sexual stages of C. parvum life cycle. To investigate whether human small intestinal organoids can be used as an in vitro culture system for Cryptosporidium, we infected expanding and differentiated small intestinal organoids with C. parvum (one of the most common Cryptosporidium species responsible for infection in humans). Because the apical side of the epithelial cells faces the lumen of the organoids, we introduced oocysts into the lumen of the organoids by microinjection (Fig. 1b) . To examine whether the parasites could propagate within the organoids, we quantified the presence of parasites at different time points after injection by quantitative PCR (qPCR) of C. parvum 18S rRNA (Fig. 1c ). In both expanding and differentiated organoids, C. parvum rRNA increased by orders of magnitudes at one day post infection. Parasite presence remained high at day six. Of note, C. parvum infection and propagation was about tenfold more efficient in differentiated organoids than in expanding organoids, suggesting that C. parvum mainly targets differentiated cells.
To address whether C. parvum can cycle through its developmental stages within organoids, we first performed scanning electron microscopy (SEM) imaging. We observed injected oocysts inside organoids directly after injection ( Supplementary Fig. 1a ). After six hours, we captured the moment when sporozoites excysted from the oocysts and observed early trophozoites near empty oocysts (arrow and arrowhead in Supplementary Fig. 1b , respectively), indicating that sporozoites invaded epithelial cells in organoids and developed into the next stage. Other epicellular structures including type I and II meronts formed over time (arrow and arrowhead in Supplementary Fig. 1c , respectively). In addition, abnormally elongated microvilli around trophozoites and meronts were occasionally observed, which was previously reported in the small intestine of C. parvum-infected mice (arrow in Supplementary Fig. 1d ) 25 . Together, these results suggested that C. parvum could propagate within organoids and that the phenotype observed in vivo could be recapitulated in organoids.
To clarify the identity of the epicellular stages within organoids, we performed immunofluorescence assays (IFA) using an antibody (Sporo-Glo) that detects C. parvum stages. Because each stage harbours a different number of 'zoites' (such as sporozoites, merozoites and microgametes in Fig. 1a ) and thus a distinct number of nuclei, dual staining with Sporo-Glo and DAPI allowed determination of individual stages. We observed type I meronts and possibly type II meronts with 8 and 4 nuclei, respectively, at 24 h after injection, and detected microgamonts carrying 16 nuclei at 72 h in organoids ( Fig. 1d ). To further ascertain the progression of the parasite life cycle, we performed transmission electron microscope (TEM) imaging. We observed most epicellular stages including invading sporozoite, trophozoite, releasing merozoites, empty parasitophorous vacuole, type II meront, macrogamont, zygote and developing oocyst in organoids at various time points after injection ( Fig. 1e and Supplementary Fig. 1e ) [26] [27] [28] . Altogether, our results implied that C. parvum could develop most stages efficiently within organoids. In addition, TEM images of differentiated organoids showed that the parasite infected maturing enterocytes ( Supplementary Fig. 1f ).
C. parvum can complete the entire life cycle within intestinal organoids.
Next, we investigated whether the parasites could complete their full life cycle by generating new oocysts within small intestinal organoids. To exclude the possibility that injected oocysts obscured the detection of newly formed oocysts, we isolated sporozoites after in vitro excystation and microinjected them into organoids ( Fig. 2a ). Similar to oocysts, sporozoites developed epicellular stages including trophozoites and meronts within organoids ( Supplementary Fig. 2a,b ). IFA showed that oocysts (oocyst-specific Crypt-a Glo) were detected within organoids at 72 h after injection, whereas only sporozoite signals (anti-gp15 antibody) were observed at 1 h ( Supplementary Fig. 2b ), indicating that oocysts were generated from the sporozoites. Furthermore, to examine whether the oocysts were released into the lumen of the organoids as in the in vivo situation, we mechanically dissociated the infected organoids and isolated oocysts from the organoid lumen by using oocystspecific antibody-conjugated magnetic beads. IFA using Crypt-a-Glo clearly showed isolated oocysts that were confirmed by TEM imaging ( Fig. 2b and Supplementary Fig. 2c ). Together, these data indicate that C. parvum can undergo its full replicative cycle in organoids, including the apical shedding of newly produced oocysts.
We further determined whether the newly formed oocysts were infectious. At four days post injection, we mechanically dissociated sporozoite-injected organoids and introduced these into neonatal mice through oral gavage ( Fig. 2d) 29, 30 . One week after inoculation, we examined the degree of infection in the mouse intestine by qPCR of the parasite HSP70 gene (see Methods) 31 . Mice inoculated with injected organoids showed levels of infection comparable to mice infected with oocysts obtained from calves, whereas mice treated with control organoids did not display any infection ( Supplementary Fig. 2c ). Although we previously reported that sporozoites were vulnerable to stomach passage through oral inoculation 32 , the infectivity of the other stages has not been studied. To exclude the possibility that other epicellular stages of the parasite inside organoids might infect the mice, we inoculated sporozoiteinjected organoids into mice at one day post injection (S_1d) and compared these with the mice inoculated with sporozoite-infected organoid for five days (S_5d) ( Fig. 2c ). Sporozoites developed different stages, such as trophozoites and type I and II meronts, but did not form oocysts within one day after injection (Fig. 1d,e and Supplementary Fig. 2e ). Although the mice inoculated with S_5d organoids induced significant infection by the parasite, introduction of S_1d organoids did not display any infection in the mice, indicating that infectious particles are not yet present at one day ( Fig. 2c , one-way ANOVA analysis, P = 0.011). Histological sections of the intestine from the mice confirmed that only the mice inoculated with S_5d organoids showed parasite infection in the ileum-caecum junction, a main targeting site of the parasite infection within intestine ( Fig. 2d ). Together, the mouse experiments show that human intestinal organoids support the completion of the parasite's entire life cycle from sporozoites to infectious oocysts.
To probe the potential of long-term culturing of the parasite within organoids, we injected sporozoites into expanding organoids and examined the maintenance of the parasite infection in organoids after passaging. To increase the efficiency of infection and propagation of the parasite, we induced differentiation of the organoids shortly after injection and switched back to the expansion condition one day before splitting (see Methods). Through this switching between expansion and differentiation conditions, the parasites persisted within organoids for at least 28 days, or 3 passages of organoid culture ( Supplementary Fig. 3 ). We did note a gradual decline after passaging.
Human lung organoids model C. parvum infection.
Although infection of C. parvum in respiratory tract has been reported previously, the pathophysiology of respiratory infection remains largely unknown 9, 10 . Thus, we sought to use human lung organoids to model respiratory infection of the parasite. We have recently established a human airway epithelial organoid that recapitulates bronchial airway. Lung organoid consists of basal cells, ciliated cells, goblet cells and club cells 33 . To examine whether the parasite can infect lung organoid and complete the life cycle, we microinjected oocysts into organoids and collected the organoids at various time points for quantitative PCR with reverse transcription (RT-qPCR) and IFA. Quantification of 18S rRNA showed that parasite increased dramatically within 24 h after injection, similar to the parasite growth Articles NaTure MicrObiOlOgy within small intestinal organoids in Fig. 1c (Fig. 3a) . By performing IFA using zoite-specific antibody, we verified the development of asexual (type I meront) and sexual (microgamont) stages within organoids (Fig. 3b ). From TEM imaging, we also observed that the parasite could infect secretory cells as well as non-secretory cells in lung organoid ( Supplementary Fig. 4 ). Lastly, IFA of sporozoiteinfected organoids using Crypt-a-Glo showed newly formed oocysts at six days post infection ( Fig. 3c ). Taking these findings together, . At 94 h post inoculation of organoids, the level of C. parvum heat shock protein 70 gene (HSP70) in mouse intestine was measured by qPCR (n = 3 biologically independent mice). Numbers of C. parvum stages were calculated by comparison to standards of known quantities of C. parvum. Organoids that were infected with sporozoites and incubated for five days (S_5d) were infectious to mice, whereas organoids that were infected and incubated for one day (S_1d) were not (one-way analysis of variance (ANOVA)). The lines in the scatter dot plot depict the medians with error bars (± s.d.). 'No' indicates control. d, Histological section of the ileum-caecum junction of the inoculated mice. Similar results were observed from two independent experiments. Scale bars, 1 mm.
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we concluded that human lung organoids allow the propagation of C. parvum and the completion of the full life cycle of the parasites.
Transcriptome analysis of host epithelial cells and C. parvum.
We next performed high-throughput RNA sequencing using differentiated small intestinal and lung organoids at 24 and 72 h post infection. Media-injected organoids were used as a control. Gene expression changes were already observed at 24 h (red dots, P < 0.05 in Fig. 4a ) and the number of differentially expressed genes on infection increased after 72 h in both small intestinal and lung organoids ( Fig. 4a and Supplementary Table 1 ). Gene ontology-term analysis revealed that a substantial number of genes related to cytoskeleton and cell mobility were upregulated in lung organoids at 24 h post injection, suggesting that parasite infection and subsequent formation of epicellular stages might affect cytoskeletal structures of host cells (Fig. 4b ). After 72 h, many genes associated with the type I interferon pathway increased dramatically in lung organoids (top in Fig. 4c ), which was confirmed using Gene Set Enrichment Analysis (GSEA) with significance score (bottom in Fig. 4c , nominal P < 0.01). Although the number of differentially expressed genes in small intestinal organoids was lower than that in lung organoids, the genes related to the type I interferon pathway were also enriched Articles NaTure MicrObiOlOgy on infection ( Supplementary Fig. 5 and Supplementary Table 1 ). Type II interferon has long been considered an important immune factor in response to parasite infection, while type I interferon has recently emerged as an anti-parasite effector 34, 35 . Our results support the hypothesis that type I interferon signalling is induced in epithelial cells as a response to infection by C. parvum.
Next, we analysed changes in expression in the transcriptome of C. parvum from the same sequencing data sets. Multiple C. parvum genes were differentially expressed with a large fold change between 24 and 72 h post injection (magenta dot, P < 0.05 in Fig. 4d ). Gene ontology analysis of the differentially expressed genes revealed substantial differences of protein functions between 24 and 72 h in both Articles NaTure MicrObiOlOgy small intestinal and lung organoids, indicating that distinct developmental stages of the parasites formed at these two time points ( Supplementary Fig. 5 and Supplementary Table 2 ). At 24 h, most of the enriched genes represented ribosomal proteins and rRNA subunits, suggesting that intensive biomass production occurred ( Fig. 4e and Supplementary Figs. 5 and 6 ). This is consistent with the results in Figs. 1c and 3a showing that the parasites proliferated massively within 24 h. By contrast, at 72 h, multiple oocyst-wall protein genes were upregulated, confirming that the parasites formed oocysts ( Fig. 4e and Supplementary Fig. 6 ). Taken together, these data illustrate molecular events occurring in both host cells and the parasite during infection and propagation of the parasite.
Discussion
In this study, we evaluate the usefulness of human intestinal and lung organoids as an in vitro culture system for C. parvum. We show that the parasite propagates and completes its complex life cycle within organoids. Newly generated oocysts from organoids are infectious and appear equivalent to oocysts obtained from an infected host animal.
To reveal a potential cell-type dependency of parasite infection, we exploited a feature of human intestinal organoids; that is, that organoids can be cultured under conditions that favour progenitor cells and that favour the generation of differentiated cells. Injection of the parasites into the two types of organoids demonstrated that C. parvum infected and propagated more efficiently in differentiated organoids than in highly proliferating expanding organoids. Our TEM imaging of differentiated small intestinal organoids showed that enterocytes are mainly infected by the parasite, consistent with a previous report 5 . Despite a lower efficiency of the infection, expanding organoids do support the completion of the full life cycle of the parasites. As the host cytoskeleton is reported to be important for C. parvum invasion and establishment of epicellular stages, we suspect that rapid division of expanding organoids might inhibit the development of infection and subsequently reduce propagation of the parasite 36, 37 . It is also possible that specific receptors for C. parvum infection might be mainly expressed in differentiated cells. Further studies are needed to clarify the mechanisms of cell-type specificity of infection.
C. parvum has been reported to infect the respiratory tract to result in respiratory cryptosporidiosis 9 . Our organoid culture system derived from human healthy bronchial airway demonstrates the infection and propagation of C. parvum in lung epithelia in vitro. As observed in small intestinal organoids, C. parvum establishes various epicellular stages and forms oocysts within lung organoids. This implies that lung organoids replicate the in vivo conditions of infection and thus can be used as a valuable tool to study tissue-specific pathophysiology of the parasite.
RNA sequencing revealed host epithelial responses on parasite infection in both differentiated small intestinal and lung organoids. More host genes were regulated in lung organoids compared to small intestinal organoids (Fig. 4a ). It is possible that a higher percentage of cells were infected within an individual lung organoid because the general size of lung organoids is much smaller than that of small intestinal organoids (by five-to eightfold). Yet, we cannot exclude the possibility that cells in the lung might be more sensitive to parasite infection than intestinal cells. Despite the different efficiencies, we observed upregulation of genes associated with type I interferon immunity in both small intestinal and lung organoids. Whereas type II interferon has been well studied for anti-parasite immunity, the role of type I interferon in anti-parasite response remains incompletely understood 34 . Although it has been reported that type I interferon partially inhibits the infection of C. parvum in 2D cancer cell lines, type I interferon can also enhance bacterial infection by suppressing type II interferon that mainly protects host cells from parasites in animal models 35, 38, 39 . It will be of great interest to understand the physiological roles of type I interferon in C. parvum infection.
Recently, Aldeyarbi and colleagues 26 reported that C. parvum could complete its life cycle in cell-free culture conditions within a few days. Using this system, the authors provided high-resolution TEM images of each epicellular stage [26] [27] [28] . This axenic system, however, does not recapitulate the interaction of host epithelia and the parasite. DeCicco RePass and colleagues established a 3D culture system by employing a silk scaffold seeded with colon cancer cell lines Caco2 and HT29-MTX 21 . This system supports continuous culture for 17 days and production of oocysts. Nonetheless, the authors did not show that new oocysts were functionally comparable to normal oocysts in in vivo infection. Likewise, Morada and colleagues developed a 3D culture system by providing polysulphone hollow fibres seeded with colon cancer cell line HCT-8 20 . This system supports continuous culture for six months and in vitro production of oocysts that are infectious to mice. However, the hollow fibre system is not amenable for investigation of individual stages of the parasite life cycle and the interaction between host cells and the parasites. Both the silk scaffold and the hollow fibre systems employ transformed tumour cell lines rather than native healthy host cells. In contrast, organoids derived from healthy human tissues replicate the functional cell composition and 3D structure of original tissues 1 . They provide a physiologically relevant system for parasite infection in both intestinal and lung tissues. In addition, because organoids can be adjusted to 2D cell cultures 40 , they are easily adaptable for various experimental uses-from investigating parasite development and interactions with host cells to screening drugs. As organoids also contain purely epithelial cells, they allow the study of direct interactions between host epithelia and the parasite. However, the current organoid system can still be improved. Although organoids can support continuous culture of parasites for 28 days, parasite numbers decreased over time. Also, the number of oocysts formed within organoids was smaller than in host animals. For more complex interactions with the host, establishment of organoid-immune cell co-cultures will be required. Genetic manipulation of Cryptosporidium has recently been reported 41 ; generation of genetically modified parasites in combination with an organoid culture system would allow more rapid dissection of the functions of specific parasite proteins in host-parasite interactions.
Methods
Human tissue materials. Small intestinal organoids were established from duodenal biopsy samples from healthy human donors in the previous work 42 . Endoscopic duodenal biopsy samples were obtained from individuals of different ages that had been admitted for suspected inflammation. The individuals were found to be healthy based on standard histological examination. Endoscopic biopsies were performed at the University Medical Center Utrecht and the Wilhelmina Children's Hospital. The patients' informed consent was obtained, and this study was approved by the ethical committee of the University Medical Center Utrecht.
Lung organoids were established from normal regions of bronchial airway tissue resection from non-small-cell lung cancer patients 33 . The collection of patient data and tissue for the generation and distribution of organoids was performed according to the guidelines of the European Network of Research Ethics Committees following European, national and local law. In the Netherlands, the responsible accredited ethical committees reviewed and approved the studies in accordance with the 'Wet medisch-wetenschappelijk onderzoek met mensen' (medical research involving human subjects act). The Verenigde Commissies Mensgebonden Onderzoek of the St. Antonius Hospital Nieuwegein approved protocol Z-12.55. All patients participating in this study signed informed consent forms approved by the responsible authority. In all cases, patients can withdraw their consent at any time, leading to the prompt disposal of their tissue and any derived material. Lung organoids established under protocols Z-12.55 were biobanked through Hubrecht Organoid Technology (http://hub4organoids.eu/). Future distribution of organoids to any third (academic or commercial) party will have to be authorized by the Medisch Ethische Toetsingscommissie, University Medical Centre Utrecht (METC UMCU) at request of Hubrecht Organoid Technology to ensure compliance with the Dutch medical research involving human subjects act.
Organoid culture. Small intestinal organoids were established from duodenal biopsy samples from healthy human donors in the previous work 42 . Briefly, dissociated small intestinal crypts were isolated from biopsy samples and embedded in Matrigel (BD Biosciences), and were overlaid with a Wnt-rich Articles NaTure MicrObiOlOgy medium (for expanding organoids) containing Advanced DMEM/F12 with 1 × Glutamax, 10 mM HEPES, penicillin-streptomycin, 1 × B27 (all from Invitrogen), 1 μ M N-Acetylcysteine (Sigma), 20% R-spondin1 conditioned medium, 10% Noggin conditioned medium, 50 ng ml −1 human EGF (Peprotech), 500 nM A83-01 (Tocris), 10 nM Gastrin (Tocris), 50% Wnt3a conditioned medium, 10 mM nicotinamide (Sigma), 10 μ M SB202190 (Sigma), 10 nM prostaglandin E2 (Tocris) and 10 μ M Y-27632 (Abmole). The medium was changed every two days and the expanding organoids were passaged by physical dissociation using fire-polished glass Pasteur pipette every six to seven days. To differentiate organoids, expanding small intestinal organoids were grown in a Wnt-rich medium for six to seven days after splitting, and then grown in a differentiation medium (withdrawal of Wnt, nicotinamide, SB202190, prostaglandin E2 from a Wnt-rich medium) for five days 2 .
Lung tissue was dissociated in lung organoid medium containing 1-2 mg ml −1 collagenase (Sigma) at 37 °C for 1-2 h. After washing and filtering with a 100 μ m strainer, cell pellets were embedded in BME type 2 (Trevigen) and were cultured in lung organoid medium containing Advanced DMEM/F12 with 1 × Glutamax, 10 mM HEPES, penicillin-streptomycin, 1 × B27 (all from Invitrogen), 1 μ M N-Acetylcysteine (Sigma), 10% R-spondin1 conditioned medium, 10% Noggin conditioned medium, 25 ng ml −1 human FGF7 (Peprotech), 100 ng ml −1 human FGF10 (Peprotech), 500 nM A83-01 (Tocris), 10 mM Nicotinamide (Sigma), 1 μ M SB202190 (Sigma) and 10 μ M Y-27632 (Abmole). Medium was changed every four days and organoids were passaged every two weeks 33 .
Expanding small intestinal organoids were microinjected at five to six days after seeding; differentiated small intestinal organoids were injected at five days after inducing differentiation. Lung organoids were incubated for two weeks after seeding for microinjection.
For long-term culturing of the parasite, oocysts were injected in expanding organoids. The injected organoids were grown in expansion medium for two to three days and then spent three to four days in differentiated medium. At day 7, the organoids were split 1:2. After splitting, organoids were grown in expansion medium for two to three days, which was replaced with differentiated medium for three to four days until the next split. The organoids were split every 7 days for 28 days.
Preparations of C. parvum oocysts and sporozoites for microinjection. C. parvum oocysts (Iowa strain, University of Arizona) were stored in sterile PBS with penicillin and streptomycin at 4 °C and used within two months. For microinjection, about 1 × 10 7 oocysts were incubated in 10% (v/v) Clorox bleach in PBS on ice and washed three times by centrifugation (for 3 min, at 8,000 g, at 4 °C) with 1 ml DMEM. The oocysts were resuspended in 100 μ l organoid culture medium supplemented with 0.5% (w/v) sodium taurocholate (Sigma). To visualize injection, 0.05% (w/v) non-toxic FastGreen dye (Sigma) was also added to the suspension. The medium supplemented with the same amount of sodium taurocholate and FastGreen dye was used for control injection.
For sporozoite microinjection, oocysts were pretreated with bleach and washed as described above. About 2 × 10 7 oocysts were incubated in 2-3 ml organoid culture medium supplemented with 0.75% (w/v) sodium taurocholate at 37 °C for 60-90 min. Excystation efficiency was checked using microscopy (generally 50-60%). The sporozoites were filtered through a 3 µ M polycarbonate filter (Millipore) to remove unexcysted oocysts and oocyst shells, and washed by centrifugation (for 20 min, at 3,400 g, at 4 °C) with cold DMEM. The sporozoites were resuspended in 50-100 μ l organoid culture medium supplemented with 0.05% (w/v) FastGreen dye, reducing agents (0.5 µ g µ l −1 each glutathione, taurine, betaine and cysteine) and 6.8 µ g ml −1 α -linolenic acid 20 .
Microinjection.
A glass capillary of 1 mm diameter (WPI) was pulled by micropipette puller (Shutter Instrument) and the tip of the capillary was cut by a sharp blade (the size/diameter of the capillary end was 9-12 µ m). Then, the capillary was filled with oocyst or sporozoite suspension by microloader tip (Eppendorf). The filled capillary was loaded in Femtojet 4i microinjector (Eppendorf) and used for microinjection. Around 100-200 nl suspension was injected into each organoid.
RNA isolation and RT-qPCR.
Equal numbers of oocysts were injected into each of the organoids in one drop of Matrigel. Total RNA was extracted from organoids in one to two drops of Matrigel using RNeasy Micro Kit (Qiagen) according to manufacturer's protocol, including DNaseI treatment. To normalize, 1 ng green fluorescent protein messenger RNA was added to each sample during RNA extraction. Complementary DNA was synthesized from 1 μ g total RNA using GoScript and random primer (both Promega). qPCR was performed in triplicate using the indicated primers, IQ SYBR green (BioRad) and BioRad systems. Gene expression was quantified using the Δ Δ Ct method. The Ct value of green fluorescent protein was used for normalization. Δ Ct of organoids at zero days post injection was used as the control to calculate the ratio of 18S rRNA at each time point. Cp18S forward, 5′ -TTGTTCCTTACTCCTTCAGCAC-3′ ; Cp18S reverse, 5′ -TCCTTCCTATGTCTGGACCTG-3′ 43, 44 .
Electron microscopy. For SEM, organoids were collected and incubated in Cell Recovery Solution (Corning) on ice for 20-30 min to remove Matrigel and fixed with 1% (v/v) glutaraldehyde (Sigma) in PBS at 4 °C overnight and transferred onto 12 mm poly-L-lysine-coated coverslips (Corning). The organoids were serially dehydrated by consecutive 10 min incubations in 2 ml of 10% (v/v), 25% (v/v) and 50% (v/v) ethanol/PBS; 75% (v/v) and 90% (v/v) ethanol/H 2 O; and 100% ethanol (2× ), followed by 50% (v/v) ethanol/hexamethyldisilazane (HMDS) and 100% HMDS (Sigma). Coverslips were removed from the 100% HMDS and airdried overnight at room temperature. Organoids were manipulated with 0.5 mm tungsten needles using an Olympus SZX9 light microscope and mounted onto 12 mm specimen stubs (Agar Scientific). Following gold coating to 1 nm using a Q150R sputter coater (Quorum Technologies) at 20 mA, samples were examined with a Phenom PRO table-top scanning electron microscope (Phenom-World).
For TEM, organoids were placed in Matrigel on 3 mm diameter and 200 µ m depth standard flat carriers for high-pressure freezing and immediately cryoimmobilized using a Leica EM high-pressure freezer (equivalent to the HPM10), then stored in liquid nitrogen until further use. They were freeze substituted in anhydrous acetone containing 2% osmium tetroxide and 0.1% uranyl acetate at -90 °C for 72 h and warmed to room temperature at 5 °C per hour (EM AFS-2, Leica). The samples were kept for 2 h at 4 °C and for 2 h more at room temperature. After several acetone rinses (4 × 15 min), samples were infiltrated with Epon resin for 2 days (acetone/resin, 3:1 for 3 h; 2:2 for 3 h; 3:1 overnight; pure resin for 6 h + overnight + 6 h + overnight + 3 h). Resin was polymerized at 60 °C during 96 h. Ultrathin sections from the resin blocks were obtained using a Leica Ultracut UC6 ultramicrotome and mounted on formvar-coated copper grids. They were stained with 2% uranyl acetate in water and lead citrate. Sections were observed in a Tecnai T12 Spirit equipped with an Eagle 4kx4k camera (FEI Company) and large electron microscopy overviews were collected using the principles and software described previously 45 .
For TEM of isolated oocysts from the organoids, isolated oocysts were washed three times with PBS and fixed overnight at 4 °C in ½ Karnovsky's Fixative (2% paraformaldehyde, 2.5% glutaraldehyde, in 0.1 M cacodylate buffer pH 7.2). The samples were then microwaved in a Pelco Biowave Pro 36500 Laboratory Microwave (Ted Pella Inc.) for 45 s at 200 W with a temperature restriction of 35 °C. The samples were rinsed with 0.1 M cacodylate buffer pH 7.2 and post fixed in 2% buffered OsO4 for 2 h at room temperature. The samples were rinsed with water and dehydrated with a 10% graded Ethanol series. The samples were infiltrated overnight with one part propylene oxide and one part Spurr's resin. The cap was removed and the propylene oxide was allowed to evaporate overnight. The resin was exchanged three times with fresh 100% Spurr's resin and left overnight. The samples were embedded in new Spurr's resin and cured for 24 h at 70 °C. Thin sections of approximately 70 nm were taken with a Leica Reichert Ultracut R (Leica Microsystems) equipped with a diamond knife and placed on formvar-coated slot grids. The samples were stained for 20 min in 2% uranyl acetate (aqueous) and for 6 min in Reynolds lead. Micrographs were taken with an FEI Technai G2 20 Twin TEM (Thermo Fisher Scientific).
Immunofluorescence staining. Organoids were collected and incubated in Cell Recovery Solution (Corning) on ice for 20-30 min to remove Matrigel. The organoids were fixed with 4% paraformaldehyde overnight at 4 °C, permeabilized with 0.2% v/v Triton X-100 (Sigma) in PBS at room temperature for 20 min and incubated in blocking solution (2% v/v goat serum, 0.1% v/v Tween-20 in PBS) at room temperature for 1 h. The organoids were subsequently incubated with anti-gp15 antibody diluted in blocking solution at 4 °C overnight, washed three times with 0.1% Tween-20 in PBS and incubated with secondary antibody (Alexa 568 goat anti-rabbit), phalloidin-Alexa 674 and DAPI (all Invitrogen) at room temperature for 2 h. After washing three times with 0.1% Tween-20 PBS, a fluorescein-labelled antibody, Crypt-a-Glo or Sporo-Glo (Waterborne), was added to label oocysts or intracellular stages of the parasite, respectively, and incubated at room temperature for 1 h. After washing once with 0.1% Tween-20 PBS, the organoids were mounted in VECTASHIELD hard-set antifade mounting medium (VectorLabs). Samples were imaged on SP8 confocal microscopes using LAS X software (all Leica) and processed using ImageJ.
Isolation of oocysts from organoids.
Organoids were collected, incubated in Cell Recovery Solution (Corning) on ice for 20-30 min to remove Matrigel and washed twice with cold DMEM. The organoids were suspended in water, physically dissociated by pipetting and homogenization and combined with magnetic beads coated in monoclonal antibody reactive with the Cryptosporidium oocyst surface (Crypto-Grab IMS beads, Waterborne, Inc., New Orleans, LA). Oocysts were isolated by immunomagnetic separation and eluted off the beads following manufacturer's recommendations. Isolated oocysts were dried onto Superstick slides (Waterborne), fixed in methanol and reacted with a fluoresceinlabelled monoclonal antibody to the Cryptosporidium oocyst wall (Crypt-a-Clo, Waterborne). Slides were mounted in VECTASHIELD and visualized on a Leica SP8 Point Scanning Confocal Microscope.
Animal experiments.
Mouse experiments consisted of four mice (both genders used) per group. Due to the young age (eight days) and the traumatic nature of defining sex in neonatal mice, gender was not determined. Groups were (1) control uninjected organoids, (2) infected organoids and (3) commercially Articles NaTure MicrObiOlOgy available oocysts (Iowa strain, obtained from calves, University of Arizona) as a positive control. The sample size was chosen to generate statistically significant data on the infectious nature of the newly generated oocysts in organoids and compare the infection rate to commercially available oocysts. Sample size was based on the expected variation within groups, the expected differences between groups and the probable degrees of freedom necessary to detect significant differences and validate conclusions. For this evaluation, one-tailed Student's t-test and one-way ANOVA were used to compare mean infection scores between test and control groups. The assignment of animals within the three groups was done randomly using Microsoft Excel Random Number Generation Tool. All mice used in the present study were maintained in Biosafety Level 2 biocontainment at the University of Arizona in accordance with the Public Health Service (PHS) Guide for the Care and Use of Laboratory Animals and Institutional Animal Care and Use Committee (IACUC) approval.
Mouse infection experiments.
At 24 h or 96-120 h after sporozoite or control media infection, differentiated small intestinal organoids were collected and incubated in Cell Recovery Solution (Corning) on ice for 20-30 min to remove Matrigel. The organoids were washed twice with 10 ml cold DMEM. The organoids were physically dissociated by pipetting several times with fire-polished glass Pasteur pipettes and centrifuged for 20 min at 4,000 rpm at 4 °C. The pellet was resuspended in saline for inoculation.
Ten specific-pathogen-free Institute of Cancer Research (ICR) mice were used in the study. Mice were administered 100 μ l broken organoids (4 mice per sporozoite-injected organoid or control organoid) or 1 × 10e4 C. parvum oocysts (Iowa strain, for two mice) by gastric intubation. After euthanasia at 92-94 h post infection, longitudinal sections representing the entire length of the jejunum, ileum, caecum and colon were collected, processed for histopathology and stained with haematoxylin and eosin. Slides were then examined histologically for C. parvum stages in mucosal epithelium 46 .
To quantify the level of infection with C. parvum, qPCR was performed as described previously 31 . The entire intestine was extracted from each mouse and homogenized using ceramic beads in the Bead Ruptor4 (OMNI International). DNA was extracted using the QIAamp Fast DNA stool mini kit (Qiagen, Gaithersburg, MD) with the following modifications. After the addition of InhibitEx buffer, the samples were incubated at 95 °C for 5 min, followed by 5 freeze-thaw cycles using liquid nitrogen and a 37 °C water bath. Total DNA in the samples was quantified by Nanodrop (Thermo Scientific). The C. parvum HSP70 gene was chosen as the target for primers (CpHSP70F, 5′ -AACTTTAGCTCCAGTTGAGAAAGTACTC-3′ ; CpHSP70R, 5′ -CATGGCTCTTTACCGTTAAAGAATTCC-3′ , and TaqMan probe CpHSP70 5′ -AATACGTGTAGAACCACCAACCAATACAACATC-3′ ). The Taqman probe was labelled at the 5′ -end with the 6-carboxyfluorescein reporter dye (FAM) and at the 3′ -end with the 6-carboxytetramethylrhodamine quencher dye (TAMRA). For qPCR, each 20 μ l reaction contained a final concentration of 300 nM for forward primer, 900 nM for reverse primer (Invitrogen, Grand Island, NY) and 200 nM for Taqman probe (Applied Biosystems, Foster City, CA) in 10 μ l Mastermix (Applied Biosystems). Genomic DNA (2 μ l) was added and the PCR was performed in an ABI StepOne Plus Real-Time PCR System (Applied Biosystems) with cycling conditions of 15 min incubation at 95 °C followed by 40 cycles at 94 °C for 15 s and 60 °C for 1 min. Each sample was run in triplicate. A control with no template was run concurrently and was consistently negative. For standards, 1 × 10e6, 5 × 10e5, 1 × 10e5, 5 × 10e4, 1 × 10e4, 5 × 10e3 and 1 × 10e3 oocysts were used to extract genomic DNA and do qPCR with the same protocol described above. A standard curve was generated using StepOne Plus Real-Time PCR machine software. Numbers of C. parvum stages were calculated by comparison to this standard curve.
RNA sequencing. Organoids derived from two independent donors were microinjected with oocyst or control media. Total RNA was extracted from collected organoids at 24 and 72 h post injection using RNeasy Micro Kit (Qiagen) according to manufacturer's protocol including DNaseI treatment. Quality and quantity of isolated RNA were checked and measured with Bioanalyzer 2100 RNA Nano 6000 chips (Agilent). Libraries were prepared as described previously 47 and sequenced on an Illumina NextSeq500 by using 75-bp pairedend sequencing. Paired-end reads from Illumina sequencing were aligned to the human transcriptome genome and C. parvum transcriptome genome (Iowa strain) by BWA 48 . DeSeq (v1.18.0) was used for read normalization and differential expression analysis. GSEA was performed using gene lists for type I interferon response and regulation against normalized RNA sequencing reads of injected small intestinal and lung organoids using GSEA software v3.0 beta2.
Gene ontology-term analysis of C. parvum genes. Categories were assigned to the 216 significantly (P < 0.05) and differentially expressed genes of lung and small intestinal organoids at 24 or 72 h post injection by leveraging data available on CryptoDB (http://cryptodb.org) 49 . First, initial categories were prepared using computed gene ontology biologic processes. Umbrella biologic process categories were chosen for computed processes that were very specific (for example, GO:0006810, transport, instead of GO:0006605, protein targeting) using the inferred tree view of AmiGO 2 (http://amigo.geneontology.org). Next, uncategorized genes were grouped into existing umbrella categories using computed gene ontology functions using the same method as before. The remaining uncategorized genes were categorized by protein product description provided by curators of CryptoDB (for example, hypothetical protein, oocyst wall proteins, mucins, ribosomal proteins, secreted and so on). Data analysis and visualization of the number and percent of highly expressed genes in each category for each condition were accomplished in R. Groups of ten 8-day-old specific-pathogen-free (SPF) ICR mice were used to test for the infectious nature of newly generated oocysts. 3-4 mice each were fed the following 1) Control uninjected organoids 2) Infected organoids 3) Oocysts (Positive control). The sample size was chosen to generate statistically significant data on the infectious nature of the newly generated oocysts in organoids and compare the infection rate to commercially available oocysts (obtained from University of Arizona). Sample size was based on the expected variation within groups, the expected differences between groups, and the probable degrees of freedom necessary to detect significant differences and validate conclusions. For this evaluation, one tailed Student's t test and one-way ANOVA will be used to compare mean infection scores between test and control groups.
Reporting summary. Further information on
Data exclusions
Describe any data exclusions.
No data was excluded from the study
Replication
Describe whether the experimental findings were reliably reproduced.
Experimental findings were reliably reproduced atleast 3 times
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For the mice infection experiment, 10 neonates were randomly allocated into 3 groups -1) Control uninjected organoids 2) Infected organoids 3) Oocysts (Positive control). The assignment of animals within the three groups will be done randomly using Microsoft Excel Random Number Generation Tool.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Each group was assigned an arbitrary number. A different investigator then did the analysis and quantification of infection of the mouse DNA by qPCR to avoid bias.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Libraries were sequenced on an Illumina NextSeq500 by using 75-bp paired-end sequencing. Paired-end reads from Illumina sequencing were aligned to the human transcriptome genome and C. parvum transcriptome genome (Iowa strain) by Burrows-Wheeler Aligner (BWA). DeSeq (v1.18.0) was used for read normalization and differential expression analysis. Gene set enrichment analysis (GSEA) was performed using gene lists for type I interferon response and regulation against normalized RNA-seq reads of injected SI and lung organoids using GSEA software v3.0 beta2.
EM sections were observed in a Tecnai T12 Spirit equipped with an Eagle 4kx4k camera (FEI Company, The Netherlands) and large EM overviews were collected using the principles and software described previously (Faas et al., 2012) .
Briefly, a software module called MyTEM was developed to control FEI transmission electron microscopes through the TEM Scripting interface it allows for parallel data acquisition where the specimen is translated during detector readout. With this approach we record up to 10,000 2k × 2k slow-scan CCD images per day. Along with each image, MyTEM collects and archives metadata on the microscope status. MyMesh is the user interface that submits calls to MyTEM and interacts with the microscope. The user can request the collection of a queue of square, rectangular, or convex polygonal virtual slides and define imaging parameters such as the required defocus, stage settling time, overlap, and detector binning. The module MyStitch combines (stitches) the TEM images into a virtual slide, correcting for inaccuracies in specimen positioning and variations in beam intensity and detector gain (see Materials and methods). MyStitch can stitch the images "on the fly," i.e., during the data acquisition process. The virtual slides are written as a multi-resolution image pyramid to allow for rapid visualization, among others, with our Java viewer MyView.
Immuno fluorescence samples were imaged on SP8 confocal microscopes using LAS X software (all Leica) and processed using ImageJ (Version 1.51p).
Biologic processes categories were defined using the inferred tree view of AmiGO 2 (http://amigo.geneontology.org) (Carbon et al., 2009).
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For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
Oocysts were obtained from The Cryptosporidium Production Laboratory (University of Arizona, School of Animal and Comparative Biomedical Sciences) and are available commercially. Small intestine and Lung Organoid lines were generated in Hubrecht Organoid Technology/Clevers lab using published procedures (Protocol ID/number: 12-093). Future distribution of organoids to any third (academic or commercial) party will have to be authorized by the METC UMCU at request of the HUB in order to ensure compliance with the Dutch medical research involving human subjects' act.
Cell lines for Wnt, Rspo and Noggin production are available on request from Hubrecht Institute.
